Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study
This trial is a part of ZhuFeng Project (ClinicalTrials.gov, identifier NCT04035837) and a part of E-Cure Study (ClinicalTrials.gov, identifier NCT05182463).
Authors
- Lijun Zheng (ORCID: https://orcid.org/0000-0001-6154-7518)
- Hanxian Chen
- Z.M. Chen
- Yan Cheng (ORCID: https://orcid.org/0000-0001-7189-3991)
- Linli Xu (ORCID: https://orcid.org/0000-0002-7032-9464)
- Suyang Wu (ORCID: https://orcid.org/0009-0006-8158-0853)
- Jianqi Lian (ORCID: https://orcid.org/0000-0002-5549-7590)
- Jing Li (ORCID: https://orcid.org/0000-0001-9392-6600)
- Ye Zhang (ORCID: https://orcid.org/0000-0002-2573-5471)
- Limin Luo (ORCID: https://orcid.org/0000-0002-7082-2718)
- Lijun Chang (ORCID: https://orcid.org/0009-0004-1467-3254)
- Weilu Zhang
- C. Wu
- Guirong Rao
- Chun-Qiu Hao
Institutions
- Yuncheng University (CN)
- Command Hospital Air Force (IN)
- Tang Du Hospital (CN)
- Southern Medical University (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Virology Journal
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1186/s12985-025-02761-3
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71